Targedys
Edit

Targedys

http://www.targedys.com/
Last activity: 29.11.2022
Categories: Management
TargEDys® met à profit ses connaissances uniques sur l’axe intestin-cerveau pour développer et fabriquer des solutions nutritionnelles et thérapeutiques afin de réguler l’appétit et contrôler les maladies métaboliques. Nous utilisons le concept de mimétisme moléculaire pour atteindre des cibles pharmacologiques connues avec des métabolites bactériens et petites molécules dérivées.
Mentions
9
Location: France, Normandy, Rouen
Total raised: $10.27M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestors
12.04.2017Series A$3.73M-
14.04.2016Series A$6.53M-

Mentions in press and media 9

DateTitleDescriptionSource
29.11.2022TargEDys and SymbioPharm enter an exclusive partnership to l...LONGJUMEAU, France, Nov. 29, 2022 /PRNewswire/ -- TargEDys and SymbioPharm signed an exclusive marke...einpresswi...
29.11.2022TargEDys and SymbioPharm enter an exclusive partnership to l...PARIS, Nov. 29, 2022 /PRNewswire/ -- TargEDys and SymbioPharm signed an exclusive marketing and dist...en.prnasia...
29.11.2022TargEDys and SymbioPharm enter an exclusive partnership to l...LONGJUMEAU, France, Nov. 29, 2022 /CNW/ -- TargEDys and SymbioPharm signed an exclusive marketing an...einpresswi...
27.09.2022TargEDys and Inoliva announce they have entered a distributi...LONGJUMEAU, France, Sept. 27, 2022 /PRNewswire/ -- TargEDys and Inoliva, an affiliate of Abdi Ibrahi...en.prnasia...
08.06.2021TargEDys announces the publication of the first double-blind...LONGJUMEAU, France, June 8, 2021 /PRNewswire/ -- The French biotech TargEDys specialized in breakthr...en.prnasia...
08.06.2021TargEDys announces the publication of the first double-blind... LONGJUMEAU, France, June 8, 2021 /PRNewswire/ -- The French biotech TargEDys specialized in breakt...prnewswire...
12.04.2017Term Sheet — Wednesday, April 12IP-NOPE Qualtrics, the Provo, Utah-based enterprise software company famous for bootstrapping in it...fortune.co...
12.04.2017TargEDys Raises Additional €3.5M in Series A FundingTargEDys, a Paris, France-based developer of innovative microbiome-based solutions to regulate the a...finsmes.co...
14.04.2016TargEDys Raises €5.8M in Series A FundingTargEDys, a Rouen, France-based developer of solutions to regulate appetite, raised €5.8m in Series ...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In